Premium
SH3P2 suppresses osteoclast differentiation through restricting membrane localization of myosin 1E
Author(s) -
Nakamura Shota,
Masuyama Ritsuko,
Sakai Kosuke,
Fukuda Karin,
Takeda Kohsuke,
Tanimura Susumu
Publication year - 2020
Publication title -
genes to cells
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.912
H-Index - 115
eISSN - 1365-2443
pISSN - 1356-9597
DOI - 10.1111/gtc.12806
Subject(s) - osteoclast , rankl , bone resorption , microbiology and biotechnology , multinucleate , biology , macrophage colony stimulating factor , cellular differentiation , endocrinology , activator (genetics) , receptor , macrophage , biochemistry , in vitro , gene
Osteoclasts are multinucleated cells responsible for bone resorption. Src homology 3 (SH3) domain‐containing protein‐2 (SH3P2)/osteoclast‐stimulating factor‐1 regulates osteoclast differentiation, but its exact role remains elusive. Here, we show that SH3P2 suppresses osteoclast differentiation. SH3P2 knockout (KO) mice displayed decreased femoral trabecular bone mass and enhanced localization of osteoclasts on the tibial trabecular bone surface, suggesting that SH3P2 suppresses bone resorption by osteoclasts. Osteoclast differentiation based on cellular multinuclearity induced by macrophage colony‐stimulating factor and receptor activator of nuclear factor‐κB ligand (RANKL) was enhanced in bone marrow‐derived macrophages lacking SH3P2. RANKL induced SH3P2 dephosphorylation, which increased the association of actin‐dependent motor protein myosin 1E (Myo1E) with SH3P2 and thereby prevented Myo1E localization to the plasma membrane. Consistent with this, Myo1E in the membrane fraction increased in SH3P2‐KO cells. Together with the attenuated osteoclast differentiation in Myo1E knocked down cells, SH3P2 may suppress osteoclast differentiation by preventing their cell‐to‐cell fusion depending on Myo1E membrane localization.